XTX Topco »

Vyne Therapeutics shares owned by XTX Topco

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by XTX Topco from 13F filings

Historical chart of XTX Topco investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by XTX Topco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by XTX Topco

Quarter filed Position value Share count Share price at filing
2025-12-31 $46k 79k 0.58
2025-06-30 $94k 57k 1.65
2025-03-31 $52k 33k 1.58
2024-12-31 $70k 21k 3.35

More positions owned by XTX Topco

Procter & Gamble Company (PG)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Cme (CME)
Kroger (KR)
At&t (T)
Vanguard Index Fds Total Stk Mkt (VTI)
Metropcs Communications (TMUS)
First Ctzns Bancshares Inc D Cl A (FCNCA)
S&p Global (SPGI)
Albertsons Cos Common Stock (ACI)
O'reilly Automotive (ORLY)
Owl Rock Capital Corporation (OBDC)

View all positions for XTX Topco

Top funds holding Vyne Therapeutics

None
Frigate Ventures
Nantahala Capital Management
Baker Bros. Advisors
Acadian Asset Management
KVP Capital Advisors
Vanguard Group
Ikarian Capital
ADAR1 Capital Management
Geode Capital Management
Two Sigma Investments
Susquehanna International
Rangeley Capital
Boothbay Fund Management
XTX Topco

View all funds holding Vyne Therapeutics